(Total Views: 368)
Posted On: 05/07/2020 11:35:10 AM
Post# of 9124
I like this part!
"Promising early-stage technologies will initially move to Phase I, where NIH will make a modest award of funds while simultaneously supporting that inventor or company with technical and clinical experts, Collins said."
This may incentivise potential partners to license NNLX tech.
"Promising early-stage technologies will initially move to Phase I, where NIH will make a modest award of funds while simultaneously supporting that inventor or company with technical and clinical experts, Collins said."
This may incentivise potential partners to license NNLX tech.
(0)
(0)Scroll down for more posts ▼
